![Ryan Martins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Martins
Direttore Finanziario/CFO presso
89BIO, INC.
Profilo
Ryan Stephen Martins is currently Chief Financial Officer at 89bio, Inc., a position held since 2019.
Formerly, Mr. Martins was Chief Financial Officer at Revolution Medicines, Inc. in 2018; VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc. from 2015 to 2018; Senior Biotechnology Analyst at Jefferies LLC from 2014 to 2015; Senior Biotechnology Analyst at FM Partners Holdings LLC from 2013 to 2014; Vice President at Barclays Capital, Inc. from 2008 to 2011; Associate at Lehman Brothers, Inc. from 2006 to 2008; Principal at Chiron Corp.
in 2006.
Education includes degrees from Virginia Polytechnic Institute & State University (graduate, 2001), the University of Mumbai (undergraduate and graduate), Haas School of Business (MBA), and St. Xavier's College (undergraduate).
Posizioni attive di Ryan Martins
| Società | Posizione | Inizio |
|---|---|---|
| 89BIO, INC. | Direttore Finanziario/CFO | 01/07/2019 |
Precedenti posizioni note di Ryan Martins
| Società | Posizione | Fine |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Direttore Finanziario/CFO | 01/10/2018 |
| ULTRAGENYX PHARMACEUTICAL INC. | Contatto Relazioni con gli Investitori | 01/03/2018 |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2015 |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/01/2014 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Formazione di Ryan Martins
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
94
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Virginia Polytechnic Institute & State University
 Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Xavier's College
 St. Xavier's College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
